Federico Innocenti
University of North Carolina at Chapel Hill
H-index: 62
North America-United States
Top articles of Federico Innocenti
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC). | Karam Ashouri Yan Yang Joshua Millstein Sebastian Stintzing Aparna Raj Parikh | 2024/1/20 | |
Gene expression biomarkers differentiate overall survival of colorectal cancer upon targeted therapies | Akram Yazdani Azam Yazdani Raul Mendez-Giraldez Gianluigi Pillonetto Esmat Samiei | 2024/3/11 | |
CCALGB 80802 (Alliance): Impact of Sorafenib with and without Doxorubicin on Hepatitis C infection in Patients with advanced hepatocellular carcinoma | Cancer Research Communications | Ghassan K Abou-Alfa Susan M Geyer Andrew B Nixon Federico Innocenti Qian Shi | 2024/2/16 |
CCR5 and CCL5 gene expression in colorectal cancer: comprehensive profiling and clinical value | Journal for Immunotherapy of Cancer | Francesca Battaglin Yasmine Baca Joshua Millstein Yan Yang Joanne Xiu | 2024 |
Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer | European Journal of Cancer | Hiroyuki Arai Yan Yang Yasmine Baca Joshua Millstein Tadamichi Denda | 2024/2/10 |
DNA mutational profiling in patients with colorectal cancer treated with standard of care reveals differences in outcome and racial distribution of mutations | Journal of Clinical Oncology | Federico Innocenti Wancen Mu Xueping Qu Fang-Shu Ou Omar Kabbarah | 2024/2/1 |
Genome-wide association study (GWAS) and novel prognostic markers in metastatic colorectal cancer (mCRC). | Yan Yang Francesca Battaglin Shivani Soni Sandra Algaze Jae Ho Lo | 2024/1/20 | |
Germline cis variant determines epigenetic regulation of the anti-cancer drug metabolism gene dihydropyrimidine dehydrogenase (DPYD) | bioRxiv | Ting Zhang Alisa Ambrodji Huixing Huang Kelly J Bouchonville Amy S Etheridge | 2023/11/4 |
Identification of reduced ERAP2 expression and a novel HLA allele as components of a risk score for susceptibility to liver injury due to amoxicillin-clavulanate | Gastroenterology | Paola Nicoletti Andrew Dellinger Yi Ju Li Huiman X Barnhart Naga Chalasani | 2023/3/1 |
Acquired genomic alterations on first-line chemotherapy with cetuximab in advanced colorectal cancer: circulating tumor DNA analysis of the CALGB/SWOG-80405 trial (Alliance) | Journal of Clinical Oncology | Kanwal Raghav Fang-Shu Ou Alan P Venook Federico Innocenti Ryan Sun | 2023/1/20 |
Gene signatures derived from transcriptomic-causal networks stratified colorectal cancer patients for effective targeted therapy | Akram Yazdani Heinz-Josef Lenz Gianluigi Pillonetto Raul Mendez-Giraldez Azam Yazdani | 2023/12/15 | |
Common variation in a long non-coding RNA gene modulates variation of circulating TGF-β2 levels in metastatic colorectal cancer patients (Alliance) | medRxiv | Julia CF Quintanilha Alexander B Sibley Yingmiao Liu Donna Niedzwiecki Susan Halabi | 2023/12/4 |
Sequencing of genes of drug response in tumor DNA and implications for precision medicine in cancer patients | The Pharmacogenomics Journal | Nancy Gillis Amy S Etheridge Sushant A Patil D Neil Hayes Michele C Hayward | 2023/7 |
Circulating tumor DNA dynamics on front-line chemotherapy with bevacizumab or cetuximab in metastatic colorectal cancer: A biomarker analysis for acquired genomic alterations … | Kanwal Pratap Singh Raghav Fang-Shu Ou Alan P Venook Federico Innocenti Ryan Sun | 2022/1/5 | |
Survival in young-onset metastatic colorectal cancer: findings from cancer and leukemia group B (Alliance)/SWOG 80405 | JNCI: Journal of the National Cancer Institute | Marla Lipsyc-Sharf Sui Zhang Fang-Shu Ou Chao Ma Nadine Jackson McCleary | 2022/3/1 |
A resource for integrated genomic analysis of the human liver | Scientific Reports | Yi-Hui Zhou Paul J Gallins Amy S Etheridge Dereje Jima Elizabeth Scholl | 2022/9/7 |
Genome-Wide Meta-analysis Identifies Genetic Variants Associated With Glycemic Response to Sulfonylureas. Diabetes Care 2021; 44: 2673–2682 | Diabetes Care | Adem Y Dawed Sook Wah Yee Kaixin Zhou Nienke van Leeuwen Yanfei Zhang | 2021/12/1 |
Plasma protein biomarkers in advanced or metastatic colorectal cancer patients receiving chemotherapy with bevacizumab or cetuximab: results from CALGB 80405 (Alliance) | Clinical Cancer Research | Andrew B Nixon Alexander B Sibley Yingmiao Liu Ace J Hatch Chen Jiang | 2022/7/1 |
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer | Oncogene | Hiroyuki Arai Andrew Elliott Joshua Millstein Joanne Xiu Fang-Shu Ou | 2022/1/5 |
Plasma levels of angiopoietin-2, VEGF-A, and VCAM-1 as markers of bevacizumab-induced hypertension: CALGB 80303 and 90401 (Alliance) | Angiogenesis | Julia CF Quintanilha Yingmiao Liu Amy S Etheridge Akram Yazdani Hedy L Kindler | 2022/2 |
